Bortezomib in Anti-Cancer Activity: A Potential Drug
<p>26S proteasome is an intracellular; ATP dependent enzymatic complex degrades ubiquitin-tagged proteins and maintains cellular homeostasis. The orderly degraded proteins including cyclins, caspases, Bcl-xL, p53, cell adhesion molecules are involved in cell-cycle progression, tumor suppressio...
में बचाया:
मुख्य लेखकों: | Rajagopal Appavu (लेखक), Deepa Mohan (लेखक) |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
Global Journal of Cancer Therapy - Peertechz Publications,
2016-03-08.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
समान संसाधन
-
Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes.
द्वारा: Britta Stadelmann, और अन्य
प्रकाशित: (2014) -
SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
द्वारा: Pan Zhou, और अन्य
प्रकाशित: (2022) -
Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice
द्वारा: Hua Wang, और अन्य
प्रकाशित: (2018) -
Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies
द्वारा: Gül Kozalak, और अन्य
प्रकाशित: (2023) -
Development and characterization of liposomal formulation of bortezomib
द्वारा: Anil K. Deshantri, और अन्य
प्रकाशित: (2019)